Search

everythinglearnresearchcommunity

for

Search:↓

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Girls with PCOS and menstrual disorders have notably higher androgen hormone levels.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

A 7-year-old boy with a brain tumor developed early puberty, which was successfully treated with medication.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Hormonal imbalances are a key cause of missed menstrual periods in women.

Sex hormones affect reproduction, sexual development, and oral health, and it's important for dental practitioners to understand their effects and interactions.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

Testosterone is crucial for development, growth, and various body functions in mammals.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

Gene mutations can cause problems in male genital development.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Skin changes can help diagnose and manage endocrine disorders like thyroid problems, diabetes, and adrenal gland conditions.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Flutamide, an antiandrogen, has minimal impact on female rat endocrine systems and does not significantly change their reproductive cycles.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.